Moreover, they also report that in MCF12A mammary epithelial immortalized cells, the CD44+/CD24-/low profile, found to enrich for cancer stem cells in primary breast tumors [3], failed to enrich for mammosphere initiating cells [38]. This evidence concerns the gene CD44 and breast neoplasm.